CN110693796A

CN110693796A - Oxygen injection essence and preparation method and application thereof

Info

Publication number: CN110693796A
Application number: CN201911140114.5A
Authority: CN
Inventors: 郭小平
Original assignee: Xinghuang Asia Pacific Enterprise Boro Chemical Co Ltd
Current assignee: Xinghuang Asia Pacific Enterprise Boro Chemical Co Ltd
Priority date: 2019-11-20
Filing date: 2019-11-20
Publication date: 2020-01-17

Abstract

The invention belongs to the field of daily chemicals. An oxygen injection essence comprises a 1 st agent and a 2 nd agent, wherein the 1 st agent comprises the following components: phase A: butanediol, aloe, hyaluronic acid, grape fruit extract, soybean root nodule extract, water, phase B: scutellariae radix extract, folium agaves Variegatae extract, and Glycyrrhrizae radix extract; the 2 nd agent comprises the following components: and C phase: butanediol, aloe vera, water, phase D: scutellaria root extract, agave extract, glycyrrhiza glabra root extract and lactoperoxidase. The oxygen injection essence disclosed by the invention can be used for injecting a large amount of oxygen into skin, improving the oxygen content of cells, activating the cells, promoting the metabolism of the skin and the permeation and absorption of effective components, effectively resisting aging and oxidation, diminishing inflammation and resisting bacteria, whitening and brightening the skin, moisturizing, softening cutin, relieving the skin, enabling the skin to be fine and compact, and relieving the problems of dryness, itching and the like of the skin.

Description

Oxygen injection essence and preparation method and application thereof

Technical Field

The invention belongs to the field of daily chemicals, and relates to oxygen injection essence and a preparation method and application thereof.

Background

The essence in the market at present is extracted from high-nutrient substances and concentrated, has the advantages of small molecules, strong permeability, good moisturizing capability and the like, but generally contains more chemical preparations, is easy to stimulate the skin, causes skin sensitivity and can cause skin dependence.

In the prior art, the essence taking plant extracts as main active ingredients has the characteristics of mildness and no stimulation, but the plant extracts are complex in ingredients, the active ingredients and beneficial effects are not clear, the effects are not obvious or even have no effects claimed by products, the active ingredients of the plant extracts are easily influenced by an extraction process, and other components and storage modes in the essence are easy to damage the stability of the plant extracts and the high activity of active substances, so that the essence is deteriorated and loses efficacy. The existing essence is mostly stored in a small bottle and taken at any time, so that the stability and high activity of the effective components of the essence are difficult to ensure.

The existing essence on the market is difficult to realize good effects of moisturizing, whitening, compacting, resisting bacteria, diminishing inflammation, resisting aging and resisting oxidation on the basis of being mild, free of stimulation, good in stability of effective components and high in activity.

Disclosure of Invention

The invention aims to solve the technical problem of providing an oxygen injection essence which can inject a large amount of oxygen into skin, improve the oxygen content of cells, activate cells, promote the metabolism of the skin and the penetration and absorption of effective components, effectively resist aging and oxidation, diminish inflammation and resist bacteria, whiten and lighten the skin, replenish water and keep moisture, soften cutin, relieve the skin, enable the skin to be fine and compact, and relieve the problems of dryness, pruritus and the like of the skin.

The technical scheme of the invention is as follows:

an oxygen injection essence comprises a 1 st agent and a 2 nd agent, wherein the 1 st agent comprises the following components in percentage by weight:

phase A: 0.5 to 20 percent of butanediol,

0.5 to 10 percent of aloe,

0.01 to 0.1 percent of hyaluronic acid,

0.3 to 2 percent of grape fruit extract,

0.5 to 2 percent of soybean root nodule extract,

60-85% of water;

phase B: 0.01-0.5% of scutellaria root extract,

0.2 to 0.5 percent of agave extract,

0.1-5% of glycyrrhiza glabra root extract;

the agent 2 comprises the following components in percentage by weight:

and C phase: 0.5 to 20 percent of butanediol,

0.5 to 10 percent of aloe,

60-85% of water;

phase D: 0.01-0.5% of scutellaria root extract,

0.2 to 0.5 percent of agave extract,

0.5-5% of glycyrrhiza glabra root extract,

0.01-1% of lactoperoxidase.

Further, the phase A in the 1 st agent also comprises allantoin 0.01-0.5%.

Further, the phase B in the 1 st agent and the phase D in the 2 nd agent further comprise at least one of the following components: 0.01-1% of centella asiatica extract, 0.01-0.5% of tea extract, 0.01-0.5% of polygonum cuspidatum root extract, 0.01-0.5% of rosemary leaf extract, 0.01-0.5% of chamomile extract and 0.01-0.2% of panthenol.

Further, the phase C in the 2 nd agent also comprises at least one of the following components: 0.01-0.5% of allantoin and 0.01-1% of carrageenan.

The preparation method of the oxygen injection essence comprises the following steps:

a. heating water in phase A to 80-85 deg.C, maintaining the temperature for 30-60min, adding the rest components in phase A, stirring, cooling to 38-40 deg.C, adding components in phase B, stirring to dissolve completely, cooling, and vacuum packaging to obtain the 1 st agent;

b. heating water in the C phase to 80-85 deg.C, maintaining the temperature for 30-60min, adding the rest components in the C phase, stirring, cooling to 35-40 deg.C, adding the components in the D phase, stirring to dissolve completely, cooling, and vacuum packaging to obtain the second preparation 2.

The application of the oxygen injection essence is to mix the 1 st and 2 nd agents with equal mass.

The invention has the following beneficial effects:

the grape fruit extract and the aloe which are selected by the invention have good antibacterial, anti-inflammatory, free radical scavenging, anti-aging and anti-oxidation effects, and are capable of moisturizing and firming skin; the selected hyaluronic acid and scutellaria root extract can effectively improve the water content of the skin, moisturize for a long time, prevent wrinkles and resist wrinkles and delay skin aging; the selected agave can effectively inhibit the decomposition of hyaluronic acid, ensure the stability, high efficiency and durability of hyaluronic acid in the components, further improve the water replenishing and moisturizing performances, increase the water content of cuticle, soften cuticle, resist allergy, relieve, crease and resist aging; the glycyrrhiza glabra extract can effectively inhibit melanin and resist free radicals, whiten and brighten skin, resist bacteria and inflammation, resist aging and resist oxidation. The components are synergistic to relieve skin, and effectively relieve the problems of dryness, itching and the like of the skin.

The soybean root nodule extract selected by the invention has good moisturizing effect, can delay skin aging, and can activate and lighten the skin; the compound lactoperoxidase has antibacterial and antioxidant properties, and can generate a large amount of oxygen when being contacted with skin cells, improve oxygen content of the skin cells, activate the cells, and promote metabolism of the skin cells, so that permeation and absorption of other active substances in essence are promoted.

The preparation method of the invention limits the adding sequence and the preparation temperature and time of each phase component in the two preparations, does not destroy the active ingredients of the extract of the plant in the fine Huazhong on the basis of ensuring that the substances of each component can be mutually dissolved and uniformly mixed, and furthest reserves the high activity of the effective substances. The two preparations are respectively vacuum-packed, so that the stability and high activity of active substances in the essence are ensured, and the failure caused by the early contact of the soybean root nodule extract and lactoperoxidase is avoided. When in use, after the two preparations with equal mass are mixed, the essence after generating oxygen is coated on skin, and the generation of the oxygen gives the essence good skin feeling and use experience.

Detailed Description

The present invention will be described in detail with reference to examples, which are only preferred embodiments of the present invention and are not intended to limit the present invention.

Examples

The following table shows the formulation of 3 examples of the oxygen injecting essence of the present invention (unit:%).

Comparative example

The following table shows the formulation of 3 comparative examples of the oxygen injecting essence of the present invention (unit:%), prepared by conventional stirring and mixing in the art.

The performances of the phases of the oxygen-injecting essence of the invention in examples 1 to 3 and comparative examples 1 to 3 were tested:

1. and (3) testing items: skin melanin content, skin whiteness, skin brightness, moisture content, moisture loss, gloss, skin elasticity.

2. Testing an instrument: CK MPA580 skin tester, Mexameter skin melanin and heme test probes, Colrometer skin color test probes, Corneometer moisture test probes, Tewameter moisture loss probes, Glossimeter gloss test probes, Cutomer skin elasticity test probes.

3. Subjects eligible volunteers were screened and faces were selected as test sites, the basal skin brightness ITA ° was between II ~ IV grades according to the Chardon group method, 20 subjects in each of examples 1-3 and comparative examples 1-3.

4. And (3) testing period: the test period was 15 days, and the respective indices were measured 1 day before using the sample and 8 and 15 days after using the instrument. In post-use testing, volunteers did not use the sample on the day of testing, and required re-use of the sample after testing was completed.

5. Sample use: the 1 week prior to testing was the elution period during which subjects used basal moisturizing water and moisturizing milk without any actives. Other skin care products cannot be used during testing. The subject used the sample once a day during the test period, before sleeping at night, and after cleaning the skin, the agent 1 and the agent 2 with the same quality as in examples 1-3 were mixed to generate oxygen and then directly applied to the skin surface, or the agent 1-3 was directly applied to the skin surface. Melanin content, whiteness, brightness were tested with the neck as a self control.

6. The testing process comprises the following steps: data acquisition before use: before testing, sit in a constant temperature and humidity room with the temperature of 24 +/-1 ℃ and the humidity of 55 +/-5% RH for 20 minutes. The pre-use data was collected at the test site using a Colormeter skin color test probe, a Mexameter skin melanin and hemoglobin test probe, a Corneometer moisture test probe, a Tewameter moisture loss probe, a Glossymeter gloss test probe, and a Cutometer skin elasticity test probe. And (4) carrying out cycle test on each test point of each test part for 4 times, and taking an average value as the data before use of the corresponding part.

7. Data acquisition 8 and 15 days after use, and the steps are the same as those of data acquisition before use.

8. Test results

(1) Rate of change of skin melanin content:

time (sky)	Example 1	Example 2	Example 3	Comparative example 1	Comparative example 2	Comparative example 3
							8	-12.57%	-12.94%	-13.61%	-9.63%	-9.89%	-9.76%
15	-15.68%	-16.32%	-16.87%	-13.45%	-14.13%	-14.25%

(2) Skin whiteness rate:

time (sky)	Example 1	Example 2	Example 3	Comparative example 1	Comparative example 2	Comparative example 3
							8	2.32%	2.49%	2.64%	1.24%	1.35%	1.37%
15	2.57%	2.61%	2.72%	1.38%	1.57%	1.63%

(3) Skin brightness change rate:

time (sky)	Example 1	Example 2	Example 3	Comparative example 1	Comparative example 2	Comparative example 3
							8	9.36	9.47	9.65	5.23	5.56	5.64
15	14.37	15.28	25.96	9.54	10.02	10.35

(4) Rate of change of moisture content:

time (sky)	Example 1	Example 2	Example 3	Comparative example 1	Comparative example 2	Comparative example 3
							8	23.36%	23.58%	24.16%	15.98%	17.32%	16.51%
15	31.67%	33.54%	33.98%	20.14%	22.07%	21.42%

(5) Water loss change rate:

time (sky)	Example 1	Example 2	Example 3	Comparative example 1	Comparative example 2	Comparative example 3
							8	-13.49	-13.89	-14.01	-9.35	-10.57	-10.22
15	-14.52	-14.96	-15.27	-10.80	-11.64	-11.25

(6) Gloss change rate:

time (sky)	Example 1	Example 2	Example 3	Comparative example 1	Comparative example 2	Comparative example 3
							8	7.43	7.85	7.91	5.21	5.62	5.63
15	7.85	8.21	8.42	6.59	7.02	7.08

(7) Rate of change of skin elasticity:

time (sky)	Example 1	Example 2	Example 3	Comparative example 1	Comparative example 2	Comparative example 3
							8	5.21	5.56	5.74	3.61	3.87	3.94
15	7.44	7.83	8.01	4.34	4.51	4.67

Therefore, the oxygen injection essence has the effects of well lightening skin melanin, improving the whiteness, brightness and glossiness of skin, and increasing the moisture content and skin elasticity of skin.

The oxygen injection essence disclosed by the invention can be used for injecting a large amount of oxygen into skin, improving the oxygen content of cells, activating the cells, promoting the metabolism of the skin and the permeation and absorption of effective components, effectively resisting aging and oxidation, diminishing inflammation and resisting bacteria, whitening and brightening the skin, moisturizing, softening cutin, relieving the skin, enabling the skin to be fine and compact, and relieving the problems of dryness, itching and the like of the skin.

Claims

1. The oxygen injection essence is characterized by comprising a 1 st agent and a 2 nd agent, wherein the 1 st agent comprises the following components in percentage by weight:

phase A: 0.5 to 20 percent of butanediol,

0.5 to 10 percent of aloe,

0.01 to 0.1 percent of hyaluronic acid,

0.3 to 2 percent of grape fruit extract,

0.5 to 2 percent of soybean root nodule extract,

60-85% of water;

phase B: 0.01-0.5% of scutellaria root extract,

0.2 to 0.5 percent of agave extract,

0.1-5% of glycyrrhiza glabra root extract;

the agent 2 comprises the following components in percentage by weight:

and C phase: 0.5 to 20 percent of butanediol,

0.5 to 10 percent of aloe,

60-85% of water;

phase D: 0.01-0.5% of scutellaria root extract,

0.2 to 0.5 percent of agave extract,

0.5-5% of glycyrrhiza glabra root extract,

0.01-1% of lactoperoxidase.

2. The oxygen infusion concentrate of claim 1 wherein phase a of the 1 st dose further comprises allantoin 0.01-0.5%.

3. The oxygen infusion concentrate of claim 1 wherein phase B in the 1 st dose and phase D in the 2 nd dose further comprise at least one of the following components: 0.01-1% of centella asiatica extract, 0.01-0.5% of tea extract, 0.01-0.5% of polygonum cuspidatum root extract, 0.01-0.5% of rosemary leaf extract, 0.01-0.5% of chamomile extract and 0.01-0.2% of panthenol.

4. The oxygen infusion essence of claim 1 wherein the phase C of the 2 nd dose further comprises at least one of the following components: 0.01-0.5% of allantoin and 0.01-1% of carrageenan.

5. The preparation method of the oxygen injection essence of claim 1, which is characterized by comprising the following steps:

heating water in phase A to 80-85 deg.C, maintaining the temperature for 30-60min, adding the rest components in phase A, stirring, cooling to 38-40 deg.C, adding components in phase B, stirring to dissolve completely, cooling, and vacuum packaging to obtain the 1 st agent;

heating water in the C phase to 80-85 deg.C, maintaining the temperature for 30-60min, adding the rest components in the C phase, stirring, cooling to 35-40 deg.C, adding the components in the D phase, stirring to dissolve completely, cooling, and vacuum packaging to obtain the second preparation 2.

6. The application of the oxygen injection essence of claim 1, wherein the 1 st agent and the 2 nd agent are mixed and used in equal mass.